当前位置: 首页 > 期刊 > 《健康必读·中旬刊》 > 20116
编号:13767894
120例婴幼儿手足口病药物治疗效果临床观察
http://www.100md.com 2011年6月1日 赵 鲜
第1页

    参见附件。

     [摘要]目的:为观察炎琥宁、利巴韦林联合治疗小儿手足口病的疗效。方法:将120例婴幼儿手足口病随机分为治疗组和对照组,每组60例,均给利巴韦林及对症治疗,治疗组加用炎琥宁治疗,比较两组疗效。结果:治疗组的总有效率为93.33%,对照组的总有效率为75%,差异有统计学意义(P<0.05)。结论:炎琥宁、利巴韦林联合治疗婴幼儿手足口病,疗效确切,未见明显不良反应。

    [关键词]婴幼儿;手足口病;炎琥宁;利巴韦林;疗效;临床观察

    [Abstract]ObjectiveTo observe the effect of using both Potassium Sodium Pehydroandroandrographolide Succinate and Ribavirinto cure infant hand-foot-mouth disease. Methods120 infant hand-foot-mouth disease patients were divided into therapy group and control group (60 cases per group). Patients in these two groups were both given cure of Ribavirinin time. But the therapy group also add Potassium Sodium Pehydroandroandrographolide Succinate to cure infant hand-foot-mouth disease at the same time. To compare the curative effect of these two groups. ResultsThe total effective rate of therapy group was 93.33%, and the total effective rate of control group was 75%. Obciously decreased as compared with that in the control group (p<0.05). ConclusionThe curative effect of using both Potassium Sodium Pehydroandroandrographolide Succinate and Ribavirinto cure infant hand-foot-mouth disease was curative and exact ......

您现在查看是摘要介绍页,详见PDF附件